Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208100 · ClinicalTrials.gov registry record · NA
Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands
A NA study of Benign Pigmented Lesions, sponsored by CynosureLutronic.
- Active
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT04208100 is a NA study of Benign Pigmented Lesions that is active but no longer recruiting, run by CynosureLutronic. The registered enrollment target is 41 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04208100, a NA study of Benign Pigmented Lesions, is active but no longer recruiting, sponsored by CynosureLutronic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, multi-site, non-randomized study of up to 40 treated subjects; subjects enrolled may be greater than subjects treated.
Conditions Studied
Interventions
- DEVICE PicoPlus
Study Locations (1)
Massachusetts
- William LoVerme, MD - Billerica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-09-13 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04208100
The ClinicalTrials.gov registry entry for NCT04208100 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CynosureLutronic, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Benign Pigmented Lesions appearing as the primary indexed condition, and to 1 intervention - of which PicoPlus is the first listed.
NCT04208100 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04208100 about?
NCT04208100 is a clinical study titled "Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands". Prospective, multi-site, non-randomized study of up to 40 treated subjects; subjects enrolled may be greater than subjects treated.
What is the current status of trial NCT04208100?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 41 participants. The study started on 2018-09-13. Estimated completion is 2020-03-31.
What conditions does trial NCT04208100 study?
This clinical trial studies the following conditions: Benign Pigmented Lesions.
What interventions are being tested in trial NCT04208100?
The interventions under investigation include: PicoPlus (DEVICE).
Who is sponsoring clinical trial NCT04208100?
This trial is sponsored by CynosureLutronic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04208100 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Pigmented Lesions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.